Health Cor Management, L.P. Immuno Gen, Inc. Transaction History
Health Cor Management, L.P.
- $106 Million
- Q4 2022
A detailed history of Health Cor Management, L.P. transactions in Immuno Gen, Inc. stock. As of the latest transaction made, Health Cor Management, L.P. holds 150,000 shares of IMGN stock, worth $0. This represents 0.7% of its overall portfolio holdings.
Number of Shares
150,000
Previous 1,300,000
88.46%
Holding current value
$0
Previous $6.21 Million
88.03%
% of portfolio
0.7%
Previous 0.78%
Shares
7 transactions
Others Institutions Holding IMGN
# of Institutions
14Shares Held
1.41MCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8721KShares$00.02% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC416KShares$03.65% of portfolio
-
Kellner Capital, LLC New York, NY69.2KShares$03.7% of portfolio
-
Leo Brokerage, LLC25KShares$00.05% of portfolio
-
Baystate Wealth Management LLC24.1KShares$00.05% of portfolio
About ImmunoGen, Inc.
- Ticker IMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 220,712,992
- Description
- ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...